Editorial: Alzheimer's Disease: Original Mechanisms and Translational Impact.
作者信息
Mancuso Cesare, Gaetani Silvana
机构信息
Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
Institute of Pharmacology, Università Cattolica del Sacro Cuore, Rome, Italy.
出版信息
Front Pharmacol. 2020 Feb 26;11:157. doi: 10.3389/fphar.2020.00157. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: Alzheimer's Disease: Original Mechanisms and Translational Impact.社论：阿尔茨海默病：原始机制与转化影响
Front Pharmacol. 2020 Feb 26;11:157. doi: 10.3389/fphar.2020.00157. eCollection 2020.
2
EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.临床前阿尔茨海默病中补偿机制的脑电图证据。
Brain. 2019 Jul 1;142(7):2096-2112. doi: 10.1093/brain/awz150.
3
Dendritic Spine and Synaptic Plasticity in Alzheimer's Disease: A Focus on MicroRNA.阿尔茨海默病中的树突棘与突触可塑性：聚焦于微小RNA
Front Cell Dev Biol. 2020 May 5;8:255. doi: 10.3389/fcell.2020.00255. eCollection 2020.
4
Editorial: The Molecular Mechanisms of Synaptic Plasticity Impairments in Alzheimer's Disease.社论：阿尔茨海默病中突触可塑性损伤的分子机制
Front Cell Dev Biol. 2022 Jan 21;10:832728. doi: 10.3389/fcell.2022.832728. eCollection 2022.
5
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.认知健康的老年疑似非阿尔茨海默病病理生理学 (SNAP) 或阿尔茨海默病病理个体的临床和认知轨迹：一项纵向研究。
Lancet Neurol. 2016 Sep;15(10):1044-53. doi: 10.1016/S1474-4422(16)30125-9. Epub 2016 Jul 20.
6
Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances.阿尔茨海默病临床前研究中的谷氨酸受体：最新进展综述。
Pharmacol Biochem Behav. 2012 Feb;100(4):855-62. doi: 10.1016/j.pbb.2011.04.013. Epub 2011 Apr 22.
7
Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease.用于检测临床前阿尔茨海默病的脑脊液生物标志物的最新进展。
Curr Opin Neurol. 2016 Dec;29(6):749-755. doi: 10.1097/WCO.0000000000000399.
8
Editorial: Progress of Translational Medicine in Alzheimer's Disease.社论：阿尔茨海默病转化医学的进展
Front Aging Neurosci. 2022 Jul 8;14:970044. doi: 10.3389/fnagi.2022.970044. eCollection 2022.
9
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases.新的药物治疗在阿尔茨海默病和帕金森病中显示出神经保护作用。
Neural Regen Res. 2014 Nov 1;9(21):1870-3. doi: 10.4103/1673-5374.145342.
10
Molecular genetics of Alzheimer's disease and aging.阿尔茨海默病与衰老的分子遗传学
Methods Find Exp Clin Pharmacol. 2005 Jul;27 Suppl A:1-573.
本文引用的文献
1
Alzheimer's disease drug development pipeline: 2019.2019年阿尔茨海默病药物研发进程
Alzheimers Dement (N Y). 2019 Jul 9;5:272-293. doi: 10.1016/j.trci.2019.05.008. eCollection 2019.
2
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.解析具有生物活性的人源 AD 脑可溶性 Aβ 的突触功能障碍，为阿尔茨海默病提供新的治疗途径。
Acta Neuropathol Commun. 2018 Nov 8;6(1):121. doi: 10.1186/s40478-018-0626-x.
3
Aβ dimers induce behavioral and neurochemical deficits of relevance to early Alzheimer's disease.Aβ 二聚体引起与早期阿尔茨海默病相关的行为和神经化学缺陷。
Neurobiol Aging. 2018 Sep;69:1-9. doi: 10.1016/j.neurobiolaging.2018.04.005. Epub 2018 Apr 17.
4
An Estimate of Attributable Cases of Alzheimer Disease and Vascular Dementia due to Modifiable Risk Factors: The Impact of Primary Prevention in Europe and in Italy.可改变风险因素导致的阿尔茨海默病和血管性痴呆归因病例估计：欧洲及意大利一级预防的影响
Dement Geriatr Cogn Dis Extra. 2018 Feb 21;8(1):60-71. doi: 10.1159/000487079. eCollection 2018 Jan-Apr.
5
Lessons from Anti-Amyloid-β Immunotherapies in Alzheimer Disease: Aiming at a Moving Target.阿尔茨海默病抗β淀粉样蛋白免疫疗法的启示：针对移动的目标。
Neurodegener Dis. 2017;17(6):242-250. doi: 10.1159/000478741. Epub 2017 Aug 9.
6
The contribution of transgenic and nontransgenic animal models in Alzheimer's disease drug research and development.转基因和非转基因动物模型在阿尔茨海默病药物研发中的贡献。
Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):95-111. doi: 10.1097/FBP.0000000000000296.
7
Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.靶向γ-分泌酶的药物增加阿尔茨海默病患者患癌风险和认知衰退：一项系统评价和荟萃分析
J Alzheimers Dis. 2016 Jul 6;53(4):1395-404. doi: 10.3233/JAD-160275.
8
Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis.欧洲阿尔茨海默病的患病率和发病率：一项荟萃分析。
Neurologia. 2017 Oct;32(8):523-532. doi: 10.1016/j.nrl.2016.02.016. Epub 2016 Apr 26.
9
The amyloid hypothesis of Alzheimer's disease at 25 years.阿尔茨海默病淀粉样蛋白假说25年回顾
EMBO Mol Med. 2016 Jun 1;8(6):595-608. doi: 10.15252/emmm.201606210. Print 2016 Jun.
10
Depression in Alzheimer's disease: epidemiology, mechanisms, and management.阿尔茨海默病中的抑郁：流行病学、机制与管理。
J Alzheimers Dis. 2014;42(3):739-55. doi: 10.3233/JAD-140324.
Zotero 插件